- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $26.26M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $27.4M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $1.81M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $2.16M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $2.66M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $2.96M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $39.3M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $40.32M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $48.37M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $49.67M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $50.72M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2023 | $50.53M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2023 | $52.02M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $51.96M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $52.77M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 14.08M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 14.28M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $1.75M |
| Dividends Paid | Q3 2025 · Mar 31, 2024 | $965K |
| Capex | Q3 2025 · Mar 31, 2024 | $179K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $853K |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.07 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.07 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $1.73M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $4.73M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$35K |
| Net Income | Q3 2025 · Mar 31, 2024 | $1.02M |
| Net Income | Q3 2025 · Dec 31, 2023 | $1.23M |
| Net Income | Q3 2025 · Sep 30, 2023 | −$176K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$488K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$82K |